Biotech · Private company · Baltimore, MD, US
Alcamena Stem Cell Therapeutics
Track this companyFree. Adds Alcamena Stem Cell Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- ASCT-83Phase 1 · Neuropathic PainClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy AdultsPHASE1 · RECRUITING · started Jan 6, 2026ClinicalTrials.gov NCT07363395 · fetched Nov 12, 2026
NIH awards2
- FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic PainFiscal year 2026 · $1.5MNIH RePORTER 5R44NS145934-02 · fetched Nov 12, 2026
- FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic PainFiscal year 2025 · $1.5MNIH RePORTER 1R44NS145934-01 · fetched Nov 12, 2026